RxDoctor Payments Data

Paresh Thanki, MD

Psychiatry · Valdosta, GANPI 1982786224

Payments from drug & device makers

$654in general payments, 2019–2025

Across 34 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$165
  • Sunovion Pharmaceuticals Inc.$119
  • Johnson & Johnson$91
  • AbbVie$77
  • Otsuka America Pharmaceutical, Inc.$50
  • Axsome Therapeutics, Inc.$46
  • plus $106 from 4 others

What the payments were for

  • Food & beverage$54383%
  • Education$11117%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$654 in reported general payments places this provider in the 55th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$58,113
Medicare patients
247
Services billed
677

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate62$189,919
VraylarCariprazine Hcl133$188,068
Invega TrinzaPaliperidone Palmitate16$140,863
Abilify MaintenaAripiprazole45$129,638
RexultiBrexpiprazole21$31,090
Risperdal ConstaRisperidone Microspheres22$27,627
Lurasidone Hcl137$27,566
TrintellixVortioxetine Hydrobromide37$21,393
CaplytaLumateperone Tosylate11$18,817
NuedextaDextromethorphan Hbr/Quinidine13$16,519
Divalproex Sodium ErDivalproex Sodium160$9,309
Quetiapine Fumarate495$8,717
Aripiprazole200$6,525
Haloperidol Decanoate108$5,115
Trazodone Hcl396$3,342

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta$91$358,410100 claims
AbbVieVraylar$77$188,068133 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$50$160,72866 claims
Almatica Pharma LLCSertraline Hcl$32$885179 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Valdosta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →